BIOCON
Back to All Ratios
|
BIOCON Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EV/CE(x) | 1.27 | 1.13 | 3.25 | 4.29 | 3.65 |
What is the latest EV/CE ratio of BIOCON ?
Year | EV/CE |
---|---|
Mar2024 | 1.27 |
Mar2023 | 1.13 |
Mar2022 | 3.25 |
Mar2021 | 4.29 |
Mar2020 | 3.65 |
How is EV/CE of BIOCON Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 1.27 | 12.39 | |
Mar2023 | 1.13 | -65.23 | |
Mar2022 | 3.25 | -24.24 | |
Mar2021 | 4.29 | 17.53 | |
Mar2020 | 3.65 | - |
Other Financial Ratios of BIOCON
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of BIOCON
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BIOCON | ₹39,373.7 Cr | -3.9% | 4.2% | 27.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹410,142.0 Cr | -1.5% | 9.1% | 9.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,762.0 Cr | -4.9% | -0.6% | 59.1% | Stock Analytics | |
CIPLA | ₹114,322.0 Cr | -1.8% | 1% | 0.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹111,171.0 Cr | 1.6% | 12.1% | 21.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹92,603.7 Cr | -3% | -0.9% | -7.7% | Stock Analytics |
BIOCON Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BIOCON | -3.9% |
4.2% |
27.9% |
SENSEX | -2.9% |
3.1% |
1.8% |
You may also like the below Video Courses